SCHEMBL8623980

SCHEMBL8623980

CCCN1CNS(=O)(=O)c2cnccc21

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 13/20 0.47
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
GRIA1 P42261 1/20 0.32
GRIA3 P42263 1/20 0.32
GRIA4 P48058 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8624828 0.92 GRIA2 (0.45) GRIA2CA12CA1CA2CA9
SCHEMBL8625419 0.90 GRIA2 (0.58) GRIA2CA12CA1CA2CA9
SCHEMBL8561528 0.82 GRIA2 (0.50) GRIA2CA12CA1CA2CA9
SCHEMBL14415245 0.81 GRIA2 (0.51) GRIA2CA12CA1CA2CA9
SCHEMBL8625722 0.81 GRIA2 (0.42) GRIA2CA12CA1CA2CA9
SCHEMBL8556566 0.75 GRIA2 (0.35) GRIA2CA12CA1CA2CA9
SCHEMBL8627050 0.74 GRIA2 (0.38) GRIA2CA12CA1CA2CA9
SCHEMBL18186896 0.74 PIK3CD (0.39) GRIA2CA12CA1CA2CA9
SCHEMBL28750433 0.71 GRIA2 (0.42) GRIA2
SCHEMBL5620265 0.70 GRIA2 (0.72) GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0618209-B1 Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them ADIR (FR) 1998-12-23 EP disclosed
US-5459138-A Dysfunctions of glutamatergic neurotransmission associated with learning and memory ADIR ET COMPAGNIE (FR) 1995-10-17 US disclosed
EP-0618209-A1 Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1994-10-05 EP disclosed